,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'bcsm']
 this is about more than just this drug or even breast cancer. its real advantage is that it enables us to take potent therapies directly to cancer cells. commenting on the impact of #enhertu #asco22 #bcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.